SCHEMBL8520671

SCHEMBL8520671

O=C(Cl)CCN1c2ccccc2Sc2ccc(Cl)cc21

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITGB2 P05107 1/20 0.62
ICAM1 P05362 1/20 0.62
ITGAL P20701 1/20 0.62
LMNA P02545 6/20 0.60
CYP2D6 P10635 5/20 0.60
DRD2 P14416 5/20 0.60
MAPT P10636 5/20 0.60
SMN1; SMN2 Q16637 5/20 0.60
CYP1A2 P05177 4/20 0.60
HTR1A P08908 4/20 0.60
CYP2C19 P33261 4/20 0.60
ADRA2A P08913 4/20 0.60
ADRA2B P18089 4/20 0.60
ADRA2C P18825 4/20 0.60
SLC6A2 P23975 4/20 0.60
HTR2A P28223 4/20 0.60
HTR2C P28335 4/20 0.60
SLC6A4 P31645 4/20 0.60
HRH1 P35367 4/20 0.60
DRD3 P35462 4/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6843471 0.89 LMNA (0.76) ITGB2ICAM1ITGALLMNACYP2D6
SCHEMBL13722563 0.89 MEN1 (0.73) LMNAMAPTKDM1AMEN1KMT2A
SCHEMBL27083994 0.86 ITGB2 (0.69) ITGB2ICAM1ITGALLMNACYP2D6
SCHEMBL8869747 0.84 LMNA (0.64) ITGB2ICAM1ITGALLMNACYP2D6
SCHEMBL27083995 0.83 CYP2D6 (0.65) ITGB2ICAM1ITGALLMNACYP2D6
SCHEMBL6637375 0.83 LMNA (0.74) ITGB2ICAM1ITGALLMNACYP2D6
SCHEMBL8435143 0.83 FNTA (0.66) ITGB2ICAM1ITGALLMNACYP2D6
SCHEMBL28997940 0.81 ITGB2 (0.70) ITGB2ICAM1ITGALLMNACYP2D6
SCHEMBL30349623 0.81 ITGB2 (0.70) ITGB2ICAM1ITGALLMNACYP2D6
SCHEMBL8426650 0.81 FNTA (0.61) ITGB2ICAM1ITGALLMNACYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5861394-A COMPOUNDS AS ANTIISCHEMIC AGENTS, TREATMENT OF STROKES, ANTIHEMORRHEGENIC AGENTS, ANTIDEPRESSANTS OR TREATMENT OF SICKKLE CELL ANEMIA BAYER AKTIENGESELLSCHAFT (DE) 1999-01-19 US disclosed
EP-0777481-A1 USE OF N-SUBSTITUTED PHENOTHIAZINES BAYER AG (DE) 1997-06-11 EP disclosed
WO-1996005837-A1 USE OF N-SUBSTITUTED PHENOTHIAZINES BAYER AKTIENGESELLSCHAFT (DE) 1996-02-29 WO disclosed